|
MPDZ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.730200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.191500E-02 |
| Normal-vs-Stage2 |
2.732800E-01 |
| Normal-vs-Stage3 |
1.910050E-02 |
| Normal-vs-Stage4 |
7.629800E-04 |
| Stage1-vs-Stage2 |
8.727800E-01 |
| Stage1-vs-Stage3 |
3.172400E-01 |
| Stage1-vs-Stage4 |
2.043900E-02 |
| Stage2-vs-Stage3 |
4.359000E-01 |
| Stage2-vs-Stage4 |
1.533830E-01 |
| Stage3-vs-Stage4 |
2.954000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.848000E-02 |
| Normal-vs-AfricanAmerican |
3.288600E-01 |
| Normal-vs-Asian |
1.869220E-01 |
| Caucasian-vs-AfricanAmerican |
6.482600E-01 |
| Caucasian-vs-Asian |
6.131200E-01 |
| AfricanAmerican-vs-Asian |
9.357600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.124740E-03 |
| Normal-vs-Female |
8.469600E-02 |
| Male-vs-Female |
3.112100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.134850E-01 |
| Normal-vs-Age(41-60Yrs) |
4.384400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.351630E-02 |
| Normal-vs-Age(81-100Yrs) |
2.165700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.277000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.363960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.189440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.313600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.416600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.865600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.596000E-02 |
| Classical-VS-Follicular |
1.996830E-03 |
| Classical-VS-Other |
9.065700E-02 |
| Classical-VS-Normal |
2.506600E-01 |
| Tall-VS-Follicular |
7.460400E-01 |
| Tall-VS-Other |
3.387800E-01 |
| Tall-VS-Normal |
1.286110E-02 |
| Follicular-VS-Other |
5.365200E-01 |
| Follicular-VS-Normal |
2.015200E-03 |
| Other-VS-Normal |
3.103900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.390040E-02 |
| Normal-vs-N1 |
9.859500E-02 |
| N0-vs-N1 |
5.259000E-01 |
|
|
